To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1609590
Sale price1.167,27 €
|
Salmeterol System Suitability (15 mg) (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H) |
R071V0 | N/A | 1.167,27 € | |
|
USP-1609614
Sale price1.238,55 €
|
Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate) |
R098M0 | N/A | 1.238,55 € | |
|
USP-1609625
Sale price1.107,68 €
|
Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- |
R05400 | 108928-81-0 | 1.107,68 € | |
|
USP-1609680
Sale price1.209,34 €
|
Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) |
R065T0 | N/A | 1.209,34 € | |
|
USP-1609831
Sale price1.018,88 €
|
Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) |
F0B009 | 3093141-64-8 | 1.018,88 € | |
|
USP-1609863
Sale price993,18 €
|
Saxagliptin Related Compound A (15 mg) (Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one) |
F216Y0 | 1429782-93-3 | 993,18 € | |
|
USP-1609864
Sale price993,18 €
|
Saxagliptin Related Compound B (15 mg) (Saxagliptin amide analogue (1S,3S,5S)-2-{(S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide) |
F217X0 | 1496712-39-0 | 993,18 € | |
|
USP-1609873
Sale price993,18 €
|
Saxagliptin Related Compound C (15 mg) ((1aS,4S,6aR,7aS)-4-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]hexahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione) |
F199H0 | 1350800-77-9 | 993,18 € | |
|
USP-1611117
Sale price905,54 €
|
Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) |
F059N0 | 58822-47-2 | 905,54 € | |
